SHTDF
$2.7
$
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Next Earnings
2026-02-25
Beta
0.628
Average Volume
Market Cap
Last Dividend
CIK
ISIN
CNE100000FN7
CUSIP
CEO
Wanyong Lian
Sector
Healthcare
Industry
Medical - Distribution
Full Time Employees
108217
IPO Date
2011-04-21
Status
Active
Latest News
| Title | Headline | Publisher | Date |
|---|---|---|---|
| Sinopharm Group (OTCMKTS:SHTDF) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell? | Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF - Get Free Report) shares passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $2.42 and traded as low as $2.35. Sinopharm Group shares last traded at $2.35, with a volume of 0 shares traded. Sinopharm Group Price Performance The | Defense World | 2026-01-24 03:10:44 |
| Sinopharm Group (OTCMKTS:SHTDF) Stock Price Passes Above 50 Day Moving Average – Time to Sell? | Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF - Get Free Report)'s share price passed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $2.53 and traded as high as $2.60. Sinopharm Group shares last traded at $2.4750, with a volume of 600 shares traded. Sinopharm Group Stock Performance | Defense World | 2026-01-06 05:12:53 |
Algorithm Performance
| Algorithm | Profit/Loss | Profit Factor | # Trades | Sharpe | Sortino | Efficiency |
|---|